CLADRIBINE(2-CDA) AND CYTARABINE(ARA-C) IS AN EFFECTIVE SALVAGE REGIMEN IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN

被引：0
|
作者：
Chinnaswamy, Girish [1 ]
Prasad, Maya [1 ]
Dwivedi, Pankaj [1 ]
Patil, Vijay [1 ]
Arora, Brijesh [1 ]
Banavali, Shripad [1 ]
机构：
[1] Tata Mem Hosp, Dept Med Oncol Pediat, Mumbai 400012, Maharashtra, India
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1040 / 1040
页数：1
相关论文
共 50 条
  • [31] Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia
    Cortes, J
    Estey, E
    Beran, M
    O'Brien, S
    Giles, F
    Koller, C
    Keating, M
    Kantarjian, H
    LEUKEMIA & LYMPHOMA, 2000, 36 (5-6) : 479 - 484
  • [32] Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia
    Doyen, Jerome
    Italiano, Antoine
    Peyrade, Frederic
    Bouyer, Claude
    Thyss, Antoine
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) : 744 - 745
  • [33] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    McLaughlin, Brian
    Im, Annie
    Raptis, Anastasios
    Agha, Mounzer
    Hou, Jing-Zhou
    Redner, Robert
    Duggal, Shrina
    Lin, Yan
    Smith, Clay
    Boyiadzis, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (06) : 743 - 747
  • [34] Fludarabine and cytarabine in patients with relapsed acute myeloid leukemia refractory to initial salvage therapy
    Brian McLaughlin
    Annie Im
    Anastasios Raptis
    Mounzer Agha
    Jing-Zhou Hou
    Robert Redner
    Shrina Duggal
    Yan Lin
    Clay Smith
    Michael Boyiadzis
    International Journal of Hematology, 2012, 96 : 743 - 747
  • [35] A Single Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Christian, Sonia
    Patel, Pritesh
    Esen, Aysenur
    Khan, Irum
    Sweiss, Karen
    Ghanem, Fares
    Sequeira, Christopher A.
    Shergill, Ardaman
    Quigley, John G.
    BLOOD, 2017, 130
  • [36] CHILDHOOD ACUTE MYELOGENOUS LEUKEMIA (AML) REFRACTORY TO ANTHRACYCLINE CYTARABINE (ARA-C) THERAPIES
    KALWINSKY, D
    LOOK, AT
    MIRRO, J
    DAHL, GV
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 193 - 193
  • [37] Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
    Heo, Sook-Kyoung
    Noh, Eui-Kyu
    Yu, Ho-Min
    Kim, Do Kyoung
    Seo, Hye Jin
    Lee, Yoo Jin
    Cheon, Jaekyung
    Koh, Su Jin
    Min, Young Joo
    Choi, Yunsuk
    Jo, Jae-Cheol
    BMC CANCER, 2020, 20 (01)
  • [38] Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death
    Sook-Kyoung Heo
    Eui-Kyu Noh
    Ho-Min Yu
    Do Kyoung Kim
    Hye Jin Seo
    Yoo Jin Lee
    Jaekyung Cheon
    Su Jin Koh
    Young Joo Min
    Yunsuk Choi
    Jae-Cheol Jo
    BMC Cancer, 20
  • [39] Salvage therapy for relapsed or refractory childhood acute lymphocytic leukemia by alternative administration a lymphoid- and myeloid-directed chemotherapeutic regimen consisting of dual modulation of ARA-C hydroxyurea, and etoposide
    Higashigawa, M
    Hori, H
    Hirayama, M
    Kawasaki, H
    Ido, M
    Azuma, E
    Sakurai, M
    LEUKEMIA RESEARCH, 1997, 21 (09) : 811 - 815
  • [40] Gemtuzumab Ozogamicin (GO) and Continuous Infusion Cytarabine (ARA-C) for Relapsed/Refractory Acute Myeloid Leukemia (AML) Prior to Allogeneic Stem Cell Transplantation (SCT).
    Zeidan, Amer
    Tan, Wei
    Wilding, Gregory
    Ford, LaurieAnn
    Hahn, Theresa
    Smiley, Shannon
    Battiwalla, Minoo
    McCarthy, Philip L.
    Wang, Eunice S.
    Wetzler, Meir
    BLOOD, 2008, 112 (11) : 350 - 351
12345